BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38836842)

  • 1. Circulating bacterial peptides and linked metabolomic signatures are indicative of early mortality in pediatric cirrhosis.
    Mathew B; Tripathi G; Gautam V; Bindal V; Sharma N; Yadav M; Pandey S; Sharma N; Gupta AC; Bhat SH; Saini AK; Sood V; Lal BB; Alam S; Khanna R; Maras JS
    Hepatol Commun; 2024 Jun; 8(6):. PubMed ID: 38836842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomolecular map of albumin identifies signatures of severity and early mortality in acute liver failure.
    Sharma N; Pandey S; Yadav M; Mathew B; Bindal V; Sharma N; Tripathi G; Bhat SH; Gupta A; Maiwall R; Sharma S; Sarin SK; Maras JS
    J Hepatol; 2023 Sep; 79(3):677-691. PubMed ID: 37116716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using Machine Learning to Identify Metabolomic Signatures of Pediatric Chronic Kidney Disease Etiology.
    Lee AM; Hu J; Xu Y; Abraham AG; Xiao R; Coresh J; Rebholz C; Chen J; Rhee EP; Feldman HI; Ramachandran VS; Kimmel PL; Warady BA; Furth SL; Denburg MR;
    J Am Soc Nephrol; 2022 Feb; 33(2):375-386. PubMed ID: 35017168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Levels of Metabolites Produced by Intestinal Microbes and Lipid Moieties Independently Associated With Acute-on-Chronic Liver Failure and Death in Patients With Cirrhosis.
    Bajaj JS; Reddy KR; O'Leary JG; Vargas HE; Lai JC; Kamath PS; Tandon P; Wong F; Subramanian RM; Thuluvath P; Fagan A; White MB; Gavis EA; Sehrawat T; de la Rosa Rodriguez R; Thacker LR; Sikaroodi M; Garcia-Tsao G; Gillevet PM
    Gastroenterology; 2020 Nov; 159(5):1715-1730.e12. PubMed ID: 32687928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Untargeted metabolomics as a diagnostic tool in NAFLD: discrimination of steatosis, steatohepatitis and cirrhosis.
    Masarone M; Troisi J; Aglitti A; Torre P; Colucci A; Dallio M; Federico A; Balsano C; Persico M
    Metabolomics; 2021 Jan; 17(2):12. PubMed ID: 33458794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF.
    Moreau R; Clària J; Aguilar F; Fenaille F; Lozano JJ; Junot C; Colsch B; Caraceni P; Trebicka J; Pavesi M; Alessandria C; Nevens F; Saliba F; Welzel TM; Albillos A; Gustot T; Fernández J; Moreno C; Baldassarre M; Zaccherini G; Piano S; Montagnese S; Vargas V; Genescà J; Solà E; Bernal W; Butin N; Hautbergue T; Cholet S; Castelli F; Jansen C; Steib C; Campion D; Mookerjee R; Rodríguez-Gandía M; Soriano G; Durand F; Benten D; Bañares R; Stauber RE; Gronbaek H; Coenraad MJ; Ginès P; Gerbes A; Jalan R; Bernardi M; Arroyo V; Angeli P; ; ;
    J Hepatol; 2020 Apr; 72(4):688-701. PubMed ID: 31778751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of sepsis mortality using metabolite biomarkers in the blood: a meta-analysis of death-related pathways and prospective validation.
    Wang J; Sun Y; Teng S; Li K
    BMC Med; 2020 Apr; 18(1):83. PubMed ID: 32290837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Untargeted Metabolomic Profiling of the Correlation Between Prognosis Differences and PD-1 Expression in Sepsis: A Preliminary Study.
    Bu Y; Wang H; Ma X; Han C; Jia X; Zhang J; Liu Y; Peng Y; Yang M; Yu K; Wang C
    Front Immunol; 2021; 12():594270. PubMed ID: 33868224
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasma Metabolomics Reveals Distinct Biological and Diagnostic Signatures for Melioidosis.
    Xia L; Hantrakun V; Teparrukkul P; Wongsuvan G; Kaewarpai T; Dulsuk A; Day NPJ; Lemaitre RN; Chantratita N; Limmathurotsakul D; Shojaie A; Gharib SA; West TE
    Am J Respir Crit Care Med; 2024 Feb; 209(3):288-298. PubMed ID: 37812796
    [No Abstract]   [Full Text] [Related]  

  • 10. Integrative "omic" analysis of experimental bacteremia identifies a metabolic signature that distinguishes human sepsis from systemic inflammatory response syndromes.
    Langley RJ; Tipper JL; Bruse S; Baron RM; Tsalik EL; Huntley J; Rogers AJ; Jaramillo RJ; O'Donnell D; Mega WM; Keaton M; Kensicki E; Gazourian L; Fredenburgh LE; Massaro AF; Otero RM; Fowler VG; Rivers EP; Woods CW; Kingsmore SF; Sopori ML; Perrella MA; Choi AM; Harrod KS
    Am J Respir Crit Care Med; 2014 Aug; 190(4):445-55. PubMed ID: 25054455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A universal plasma metabolites-derived signature predicts cardiovascular disease risk in MAFLD.
    Li Z; Gong R; Chu H; Zeng J; Chen C; Xu S; Hu L; Gao W; Zhang L; Yuan H; Cheng Z; Wang C; Du M; Zhu Q; Zhang L; Rong L; Hu X; Yang L
    Atherosclerosis; 2024 May; 392():117526. PubMed ID: 38581738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of biomarkers for risk assessment of arsenicosis based on untargeted metabolomics and machine learning algorithms.
    Zhang J; Ma L; Li B; Chen X; Wang D; Zhang A
    Sci Total Environ; 2023 Apr; 870():161861. PubMed ID: 36716877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between the metabolome and bone mineral density in a Chinese population.
    Mei Z; Dong X; Qian Y; Hong D; Xie Z; Yao G; Qin A; Gao S; Hu J; Liang L; Zheng Y; Su J
    EBioMedicine; 2020 Dec; 62():103111. PubMed ID: 33186808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic system alterations in pancreatic cancer patient serum: potential for early detection.
    Ritchie SA; Akita H; Takemasa I; Eguchi H; Pastural E; Nagano H; Monden M; Doki Y; Mori M; Jin W; Sajobi TT; Jayasinghe D; Chitou B; Yamazaki Y; White T; Goodenowe DB
    BMC Cancer; 2013 Sep; 13():416. PubMed ID: 24024929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Untargeted metabolomic profiling identifies disease-specific signatures in food allergy and asthma.
    Crestani E; Harb H; Charbonnier LM; Leirer J; Motsinger-Reif A; Rachid R; Phipatanakul W; Kaddurah-Daouk R; Chatila TA
    J Allergy Clin Immunol; 2020 Mar; 145(3):897-906. PubMed ID: 31669435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A metabolomics approach to the validation of predictive metabolites and phenotypic expression in non-alcoholic fatty liver disease.
    Ganesan R; Gupta H; Jeong JJ; Sharma SP; Won SM; Oh KK; Yoon SJ; Kim DJ; Suk KT
    Life Sci; 2023 Jun; 322():121626. PubMed ID: 37003543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Machine learning of plasma metabolome identifies biomarker panels for metabolic syndrome: findings from the China Suboptimal Health Cohort.
    Wang H; Wang Y; Li X; Deng X; Kong Y; Wang W; Zhou Y
    Cardiovasc Diabetol; 2022 Dec; 21(1):288. PubMed ID: 36564831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unique metabolomic signature associated with hepatorenal dysfunction and mortality in cirrhosis.
    Mindikoglu AL; Opekun AR; Putluri N; Devaraj S; Sheikh-Hamad D; Vierling JM; Goss JA; Rana A; Sood GK; Jalal PK; Inker LA; Mohney RP; Tighiouart H; Christenson RH; Dowling TC; Weir MR; Seliger SL; Hutson WR; Howell CD; Raufman JP; Magder LS; Coarfa C
    Transl Res; 2018 May; 195():25-47. PubMed ID: 29291380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarker Phenotype for Early Diagnosis and Triage of Sepsis to the Pediatric Intensive Care Unit.
    Mickiewicz B; Thompson GC; Blackwood J; Jenne CN; Winston BW; Vogel HJ; Joffe AR
    Sci Rep; 2018 Nov; 8(1):16606. PubMed ID: 30413795
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.